Results 131 to 140 of about 22,288 (223)

Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model. [PDF]

Int J Pharm X
García-Otero X, Cuartero-Martínez A, Fernández-Robredo P, Antas SG, Gómez-Lado N, Otero-Espinar FJ, Hernández M, Bezunartea J, García-Layana A, Recalde S, Aguiar P, Fernández-Ferreiro A.   +11 more
europepmc   +1 more source

Is IL-10 a Good Target to Inhibit Choroidal Neovascularisation in Age-Related Macular Disease?

, 2006
Sue Lightman, Virginia Calder, Calder, V, Lightman, S   +3 more
core   +1 more source

Real-World Outcomes in Pre-Existing Neovascular Age-Related Macular Degeneration Subjects Undergoing Avacincaptad Therapy for Geographic Atrophy

Ryan B Rush,1– 3 Westin Klein,1,3 Sloan W Rush,1,2 Robert M Reinauer4 1Department of Ophthalmology, Panhandle Eye Group, Amarillo, TX, USA; 2Department of Surgery, Texas Tech University Health Science Center, Amarillo, TX, USA; 3Department of ...
Rush RB, Rush SW, Reinauer RM, Klein W
core  

The Short-Term Outcomes of Intravitreal Faricimab for Treatment-Naïve and -Refractory Neovascular Age-Related Macular Degeneration: A Real-World Study. [PDF]

Medicina (Kaunas)
Chang HL, Wang LU, Huang TL, Chang PY, Ho WT, Hsu YR, Chen FT, Chen YJ, Lin CD, Wang JK.   +9 more
europepmc   +1 more source

Imaging and functional correlates of fibrosis in neovascular age-related macular degeneration: a systematic review. [PDF]

Front Ophthalmol (Lausanne)
Spooner KL, Fraser-Bell S, Fu DJ, Faes L, Romano F, Cozzi M, Chang AA, Sivaprasad S.   +7 more
europepmc   +1 more source

Management of fibrosis in neovascular age-related macular degeneration. [PDF]

Graefes Arch Clin Exp Ophthalmol
Chakravarthy U, Foss AJE, Panos GD, Peto T, Rotsos T, Sadda S, De Cock E, Empeslidis T.   +7 more
europepmc   +1 more source

Community Optometrist-Led Monitoring of Quiescent Neovascular Age-Related Macular Degeneration: The FENETRE Randomized Clinical Trial.

JAMA Netw Open
Sharma A, Jaber A, Pal B, Lawrenson JG, Harper RA, Tufail A, Learoyd AE, Robinson E, Douiri A, Burman R, Kernohan A, Vougioukalou S, Read S, Csontos J, Jones A, Mahmood S, McKibbin M, Peacock JL, Gale R, Patel PJ, Keane PA, Hamilton R, Vale L, Bunce C, Balaskas K.   +24 more
europepmc   +1 more source

MMP9 Genotype and Systemic T-Cell Subsets Correlate With Structural and Functional Outcomes in Neovascular Age-Related Macular Degeneration. [PDF]

Invest Ophthalmol Vis Sci
Martinez TL, Zacharias ZR, Lee K, Han IC, Jiao C, Bach BB, Roos B, Chava S, McCormick MM, Sinkey C, Wu AP, Mukhopadhyay C, Coussa RG, Russell J, Binkley EM, Boldt HC, Folk JC, Russell SR, Mullins RF, Fingert JH, Wang K, Abramoff MD, Stone EM, Scheetz TE, Houtman JCD, Sonka M, Sohn EH.   +26 more
europepmc   +1 more source

Association between optical coherence tomography biomarkers and systemic inflammatory indices in neovascular age-related macular degeneration. [PDF]

BMC Ophthalmol
Kocamış Ö.
europepmc   +1 more source

Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month Clinical Audit. [PDF]

Cureus
Sukumaran D, Benjamin D, Abdul Karim MN, Amankwah R, Maharajan P, Mubashar M, Sarmad A, Sharma P, Dhar-Munshi S.   +8 more
europepmc   +1 more source